Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cells.
Blood Adv. 2020 Dec 22;4(24):6368-6383. doi: 10.1182/bloodadvances.2020002812.
Blood Adv. 2020.
PMID: 33351133
Free PMC article.
IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP, van Gils N, Martiañez T, van Rhenen A, Rutten A, Denkers F, de Leeuw DC, Smit MA, Tsui ML, de Vos Klootwijk LLE, Menezes RX, Çil M, Roemer MGM, Vermue E, Heukelom S, Zweegman S, Janssen JJWM, Ossenkoppele GJ, Schuurhuis GJ, Smit L.
Verhagen HJMP, et al. Among authors: vermue e.
Cell Rep. 2018 Dec 11;25(11):3021-3035.e5. doi: 10.1016/j.celrep.2018.11.062.
Cell Rep. 2018.
PMID: 30540936
Free article.
Item in Clipboard
The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells.
van Gils N, Martiañez Canales T, Vermue E, Rutten A, Denkers F, van der Deure T, Ossenkoppele GJ, Giles F, Smit L.
van Gils N, et al. Among authors: vermue e.
Hemasphere. 2021 Jul 8;5(8):e610. doi: 10.1097/HS9.0000000000000610. eCollection 2021 Aug.
Hemasphere. 2021.
PMID: 34258514
Free PMC article.
Item in Clipboard
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Martiáñez Canales T, de Leeuw DC, Vermue E, Ossenkoppele GJ, Smit L.
Martiáñez Canales T, et al. Among authors: vermue e.
Cancers (Basel). 2017 Jun 30;9(7):74. doi: 10.3390/cancers9070074.
Cancers (Basel). 2017.
PMID: 28665351
Free PMC article.
Review.
Item in Clipboard
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
van Gils N, Verhagen HJMP, Broux M, Martiáñez T, Denkers F, Vermue E, Rutten A, Csikós T, Demeyer S, Çil M, Al M, Cools J, Janssen JJWM, Ossenkoppele GJ, Menezes RX, Smit L.
van Gils N, et al. Among authors: vermue e.
iScience. 2022 Aug 25;25(9):105013. doi: 10.1016/j.isci.2022.105013. eCollection 2022 Sep 16.
iScience. 2022.
PMID: 36097617
Free PMC article.
Item in Clipboard
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.
van Spronsen MF, Hanekamp D, Westers TM, van Gils N, Vermue E, Rutten A, Jansen JH, Lissenberg-Witte BI, Smit L, Schuurhuis GJ, van de Loosdrecht AA.
van Spronsen MF, et al. Among authors: vermue e.
Leukemia. 2023 Mar;37(3):680-690. doi: 10.1038/s41375-023-01811-5. Epub 2023 Feb 15.
Leukemia. 2023.
PMID: 36792658
Free PMC article.
Item in Clipboard
Cite
Cite